{"id":"https://openalex.org/W2149073952","doi":"https://doi.org/10.1093/jnci/85.3.217","title":"Model-Guided Determination of Maximum Tolerated Dose in Phase I Clinical Trials: Evidence for Increased Precision","display_name":"Model-Guided Determination of Maximum Tolerated Dose in Phase I Clinical Trials: Evidence for Increased Precision","alternate_titles":[],"publication_year":1993,"publication_date":"1993-02-03","ids":{"openalex":"https://openalex.org/W2149073952","doi":"https://doi.org/10.1093/jnci/85.3.217","mag":"2149073952","pmid":"https://pubmed.ncbi.nlm.nih.gov/8423626"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/85.3.217","doi":"https://doi.org/10.1093/jnci/85.3.217","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/85.3.217","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2149073952"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052264374","display_name":"Rosemarie Mick","orcid":"https://orcid.org/0009-0004-6215-0538","observed_orcids":["https://orcid.org/0009-0004-6215-0538"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"R. Mick","raw_affiliation_strings":["Department of Medicine, University of Chicago, Pritzker School of Medicine, Ill","Section of Hematology/Oncology, Department of Medicine and Cancer Research Center, University of Chicago, Pritzker School of MedicineChicago, Ill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Chicago, Pritzker School of Medicine, Ill","institution_ids":["https://openalex.org/I40347166"]},{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine and Cancer Research Center, University of Chicago, Pritzker School of MedicineChicago, Ill","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068268371","display_name":"Mark J. Ratain","orcid":"https://orcid.org/0000-0002-0938-4392","observed_orcids":["https://orcid.org/0000-0002-0938-4392"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. J. Ratain","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine and Cancer Research Center and Committee on Clinical Pharmacology, University of Chicago, Pritzker School of Medicine Chicago, Ill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine and Cancer Research Center and Committee on Clinical Pharmacology, University of Chicago, Pritzker School of Medicine Chicago, Ill","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5052264374"],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":1.6957,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.83055976,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"85","issue":"3","first_page":"217","last_page":"223"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10243","display_name":"Statistical Methods and Bayesian Inference","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.890999972820282},{"id":"https://openalex.org/keywords/phase-i-clinical-trial-design","display_name":"phase I clinical trial design","score":0.8889999985694885},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7170000076293945},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7120000123977661},{"id":"https://openalex.org/keywords/pharmacodynamic-modeling","display_name":"pharmacodynamic modeling","score":0.8640000224113464},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.5680000185966492},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.9120000004768372}],"concepts":[{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.7610388398170471},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.6819427609443665},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6718703508377075},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5657280087471008},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5280654430389404},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.48773011565208435},{"id":"https://openalex.org/C148482608","wikidata":"https://www.wikidata.org/wiki/Q17007018","display_name":"Clinical study design","level":3,"score":0.47776830196380615},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4140339493751526},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3655090928077698},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.361990749835968},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3333650231361389}],"mesh":[{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/85.3.217","doi":"https://doi.org/10.1093/jnci/85.3.217","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/85.3.217","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:8423626","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8423626","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.890.5942","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.890.5942","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnci.oxfordjournals.org/content/85/3/217.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1361992915","display_name":null,"funder_award_id":"N01-CM-07301","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000865577","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA014599","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G982314443","display_name":"PHASE I &CLINICAL PHARMACOKINETICS - ANTI-CANCER AGENTS","funder_award_id":"n01cm007301-003","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2013823495","https://openalex.org/W4409818080","https://openalex.org/W2156933706","https://openalex.org/W4416871545","https://openalex.org/W2788706669","https://openalex.org/W2055637937","https://openalex.org/W3146412768","https://openalex.org/W1258597325","https://openalex.org/W2365636114","https://openalex.org/W2084986158"],"abstract_inverted_index":{"BACKGROUND:":[0],"A":[1,48],"widely":[2],"used":[3],"phase":[4,56,64,99,153,165,289,331],"I":[5,65,100,154,166,290],"design":[6,67,93,119,190,274,292,348],"in":[7,24,97,183,193,235,240,298],"clinical":[8],"trials":[9],"of":[10,26,37,77,137,171,174,259,334],"chemotherapy":[11,335],"for":[12,15,21,55,214,224,270,330,336,339],"cancer":[13,337],"and":[14,50,129,162,180,219,226,255,295,301,338,358],"AIDS":[16],"(acquired":[17],"immunodeficiency":[18],"syndrome)":[19],"allows":[20,94],"dose":[22,46,53,80,294,329],"escalation":[23],"cohorts":[25,136],"three":[27],"to":[28,102,108,144,321,325,362],"six":[29],"patients.":[30],"Escalation":[31],"continues":[32],"until":[33],"a":[34,44,74,115,131,288,299],"predefined":[35],"percentage":[36,258],"patients":[38,96,138,260,360],"experience":[39],"unacceptable":[40],"toxic":[41],"effects":[42],"at":[43,105,262],"given":[45],"level.":[47],"safe":[49],"maximum":[51],"tolerated":[52],"(MTD)":[54],"II":[57,332],"study":[58,66,92,101,181,247,291],"is":[59,72,342],"then":[60],"determined.":[61],"This":[62],"standard":[63,161,189,225,313],"has":[68],"serious":[69],"inadequacies.":[70],"MTD":[71,205,237,307,352],"not":[73],"model-based":[75],"estimate":[76,147],"the":[78,84,98,148,160,184,188,194,198,208,215,232,236,241,246,256,271,306,312,327,345,351],"true":[79],"that":[81,120,287,344],"would":[82],"yield":[83],"targeted":[85],"dose-limiting":[86],"toxicity":[87,296],"rate.":[88],"Moreover,":[89,245],"this":[90],"simplistic":[91],"some":[95],"be":[103,319],"treated":[104,261],"doses":[106,264],"unlikely":[107],"have":[109],"therapeutic":[110],"efficacy.":[111],"PURPOSE:":[112],"We":[113,168],"constructed":[114],"novel":[116],"quantitative":[117,163,199,227,242,272,302,346],"assessment":[118,164,200,228,243,273,347],"repetitively":[121],"evaluates":[122],"accumulating":[123],"dose-toxicity":[124],"data":[125,297],"by":[126,158],"repeatedly":[127],"fitting":[128],"updating":[130],"pharmacodynamic":[132],"model":[133],"after":[134],"small":[135],"are":[139],"treated.":[140],"The":[141,203],"goal":[142],"was":[143,211,238,249,267],"more":[145,309,356],"accurately":[146],"MTD.":[149],"METHODS:":[150],"One":[151],"hundred":[152],"studies":[155,185,195,210,333],"were":[156],"simulated":[157,186,196],"both":[159],"designs.":[167],"compared":[169],"determination":[170],"MTD,":[172],"frequency":[173],"grade":[175],"0":[176],"leukopenia":[177],"(no":[178,265],"toxicity),":[179],"size":[182,248],"using":[187,197,293],"with":[191,308,353],"those":[192],"design.":[201,244,314],"RESULTS:":[202],"median":[204,257],"determined":[206],"from":[207],"100":[209,218],"nearly":[212],"identical":[213],"two":[216],"designs:":[217],"95":[220],"mg/m2":[221],"per":[222],"day":[223],"designs,":[229],"respectively.":[230],"However,":[231],"interstudy":[233],"variation":[234],"decreased":[239],"significantly":[250,268],"reduced":[251],"(P":[252],"<":[253,279],".0001),":[254],"subtoxic":[263],"leukopenia)":[266],"lower":[269],"(44%":[275],"versus":[276],"48%;":[277],"P":[278],".0001).":[280],"CONCLUSION:":[281],"Our":[282],"results":[283],"show":[284],"clear":[285],"evidence":[286,343],"repetitive":[300],"manner":[303],"can":[304],"identify":[305,326,350],"accuracy":[310],"than":[311],"IMPLICATIONS:":[315],"New":[316],"approaches":[317],"must":[318],"explored":[320],"improve":[322],"our":[323],"ability":[324],"optimal":[328],"AIDS.":[340],"There":[341],"will":[349],"fewer":[354,359],"patients,":[355],"precision,":[357],"exposed":[361],"suboptimal":[363],"doses.":[364]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2149073952","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}
